All News Novartis AG

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:35 2024-06-07 am EDT			5-day change	1st Jan Change
94.95 ^CHF	-0.04%		+1.91%	+11.88%

02:31pm	Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy	MT
06:43am	Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	MT

Abu Dhabi, Novartis to Collaborate on Genomics Research for Cancer Therapy	08:31am	MT
Novartis, Roche's Genentech Among Companies Facing Italian Competition Watchdog Inquiry Over Eye Drug	12:43am	MT
AlphaValue/Baader Europe Lowers Price Target on Novartis, Maintains Add Recommendation	Jun. 06	MT
Staff at drugmaker under U.S. scrutiny worked with Chinese military scientists	Jun. 06	RE
Novartis, Roche, Biogen, Samsung Bioepis in Italy Eye-Medicine Probe	Jun. 06	DJ
Novartis and others face Italy antitrust probe over eye drug	Jun. 06	RE
Cytokinetics CEO Says Board Would Have Backed Actionable Buyout	Jun. 05	DJ
The odds of rates getting cut in 2024 may be better than you think	Jun. 05
NOVARTIS AG : Deutsche Bank maintains a Buy rating	Jun. 05	ZD
Bank Vontobel Lifts Price Target on Novartis, Maintains Buy Recommendation	Jun. 04	MT
NOVARTIS AG : JP Morgan remains Neutral	Jun. 03	ZD
NOVARTIS AG : Buy rating from Goldman Sachs	Jun. 03	ZD
NOVARTIS : UBS reiterates buy recommendation after ASCO	Jun. 03	CF
NOVARTIS AG : UBS gives a Buy rating	Jun. 03	ZD
Pre-surgery treatment with Bristol Myers combination therapy leads to better skin cancer outcomes	Jun. 02	RE
NOVARTIS AG : UBS reiterates its Buy rating	May. 31	ZD
European Equities Close Higher in Friday Trading; Flash Euro Area Inflation Rises More Than Expected	May. 31	MT
Swiss Market Index in the Green Amid US Rate Cut Optimism	May. 31	MT
NOVARTIS AG : Jefferies remains its Buy rating	May. 31	ZD
Novartis Says Late-Stage Scemblix Trial Meets Primary Endpoints	May. 31	MT